CUMYL-BC-HPMEGACLONE-221
CUMYL-BC-HPMEGACLONE-221 is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that interact with the cannabinoid receptors in the endocannabinoid system.
Chemical Structure and Properties
CUMYL-BC-HPMEGACLONE-221 is chemically related to other synthetic cannabinoids. Its structure includes a cumyl group attached to a benzimidazole core, which is further connected to a cyclohexylmethyl side chain. The exact molecular formula and detailed chemical properties are essential for understanding its pharmacological effects and potential risks.
Pharmacology
As a synthetic cannabinoid, CUMYL-BC-HPMEGACLONE-221 acts on the CB1 and CB2 receptors in the endocannabinoid system. These receptors are primarily found in the central nervous system and immune system, respectively. The interaction with these receptors can lead to various psychoactive effects, including euphoria, altered perception, and relaxation.
Legal Status
The legal status of CUMYL-BC-HPMEGACLONE-221 varies by country. In some regions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use. It is important to consult local regulations to determine its legal status.
Health Risks and Safety
The use of synthetic cannabinoids like CUMYL-BC-HPMEGACLONE-221 can pose significant health risks. Adverse effects may include tachycardia, hypertension, hallucinations, and psychosis. Long-term use can lead to dependence and withdrawal symptoms. Due to the potential for severe side effects, caution is advised when encountering this substance.
Detection and Analysis
Detection of CUMYL-BC-HPMEGACLONE-221 in biological samples can be challenging due to its synthetic nature and the constant evolution of new analogs. Advanced analytical techniques such as mass spectrometry and gas chromatography are often employed to identify and quantify this compound in forensic and clinical settings.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD